Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Huffman

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Behavioural Pharmacology|July 16, 2008
Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- miceChristopher S Breivogel, Jonathan M Lambert, Steven Gerfin, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptorsJohn W Huffman, Lea W Padgett, Matthew L Isherwood, et al.
Methods Report (RTI Press)|February 12, 2013
Hijacking of Basic Research: The Case of Synthetic CannabinoidsJenny L Wiley, Julie A Marusich, John W Huffman, et al.
Bioorganic & Medicinal Chemistry|September 17, 2005
Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptorJohn W Huffman, Simon M Bushell, Sudhir N Joshi, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptorJohn W Huffman, Simon M Bushell, John R A Miller, et al.
European Journal of Pharmacology|May 28, 2009
Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J miceRobert E Vann, Jonathan A Warner, Kristen Bushell, et al.
Journal of Receptor and Signal Transduction Research|October 8, 2013
The influence of beta-arrestin2 on cannabinoid CB1 receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brainChristopher S Breivogel, Vanita Puri, Jonathan M Lambert, et al.
Pharmacology|September 11, 2002
Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinityJenny L Wiley, Reneé G Jefferson, Graeme Griffin, et al.
Bioorganic & Medicinal Chemistry|July 13, 2010
Synthesis and pharmacology of 1-methoxy analogs of CP-47,497John W Huffman, Seon A Hepburn, Patricia H Reggio, et al.
Neuropharmacology|July 25, 2016
Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in miceJenny L Wiley, Timothy W Lefever, Julie A Marusich, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Behavioural Pharmacology|July 16, 2008
Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- miceChristopher S Breivogel, Jonathan M Lambert, Steven Gerfin, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptorsJohn W Huffman, Lea W Padgett, Matthew L Isherwood, et al.
Methods Report (RTI Press)|February 12, 2013
Hijacking of Basic Research: The Case of Synthetic CannabinoidsJenny L Wiley, Julie A Marusich, John W Huffman, et al.
Bioorganic & Medicinal Chemistry|September 17, 2005
Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptorJohn W Huffman, Simon M Bushell, Sudhir N Joshi, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptorJohn W Huffman, Simon M Bushell, John R A Miller, et al.
European Journal of Pharmacology|May 28, 2009
Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J miceRobert E Vann, Jonathan A Warner, Kristen Bushell, et al.
Journal of Receptor and Signal Transduction Research|October 8, 2013
The influence of beta-arrestin2 on cannabinoid CB1 receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brainChristopher S Breivogel, Vanita Puri, Jonathan M Lambert, et al.
Pharmacology|September 11, 2002
Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinityJenny L Wiley, Reneé G Jefferson, Graeme Griffin, et al.
Bioorganic & Medicinal Chemistry|July 13, 2010
Synthesis and pharmacology of 1-methoxy analogs of CP-47,497John W Huffman, Seon A Hepburn, Patricia H Reggio, et al.
Neuropharmacology|July 25, 2016
Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in miceJenny L Wiley, Timothy W Lefever, Julie A Marusich, et al.
Pageof 4